Question 1

What is the catalog number for Compound STOCK1N-91507?

Accepted Answer

The catalog number for Compound STOCK1N-91507 is T126686.

Question 2

Is Compound STOCK1N-91507 in stock?

Accepted Answer

Compound STOCK1N-91507 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures Compound STOCK1N-91507?

Accepted Answer

Compound STOCK1N-91507 is manufactured by Molfinity.

Question 4

What is the estimated delivery time for Compound STOCK1N-91507?

Accepted Answer

Estimated delivery time for Compound STOCK1N-91507 is approximately 10 business day(s), depending on your location.

Question 5

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 6

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 7

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Compound STOCK1N-91507

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

Kallikrein 1 (KLK1) (NM_002257) Human Over-expression Lysate

Tissue FFPE Sections, Lung

THUMPD3 Rabbit Polyclonal Antibody

Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/2039), CF405S conjugate, 0.1mg/mL

Apolipoprotein A V (APOA5) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1A2]

Langerin / CD207 Recombinant Rabbit Monoclonal Antibody [JE32-54]